What Happened?
New York, NY-based Enzo Appointed Patricia Eckert as Interim Chief Financial Officer
About the Company
Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products, systems and services that meet the ever-changing and rapidly growing needs of health care today and into the future. Underpinning Enzo Biochem`s products and technologies is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies.
About the Person
Patricia Eckert is Interim Chief Financial Officer at Enzo. Previously, Patricia held various senior HR leadership roles in the industry.
Info Source
News
Short Profile